rs151234321

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_002334.4(LRP4):​c.3620A>G​(p.Asn1207Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00148 in 1,614,150 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00084 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

LRP4
NM_002334.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 0.117

Publications

8 publications found
Variant links:
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
LRP4 Gene-Disease associations (from GenCC):
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • congenital myasthenic syndrome 17
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis 2
    Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013764203).
BP6
Variant 11-46875883-T-C is Benign according to our data. Variant chr11-46875883-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 286738.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000841 (128/152260) while in subpopulation NFE AF = 0.00148 (101/68018). AF 95% confidence interval is 0.00125. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP4
NM_002334.4
MANE Select
c.3620A>Gp.Asn1207Ser
missense
Exon 26 of 38NP_002325.2O75096

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP4
ENST00000378623.6
TSL:1 MANE Select
c.3620A>Gp.Asn1207Ser
missense
Exon 26 of 38ENSP00000367888.1O75096
LRP4
ENST00000858258.1
c.3071A>Gp.Asn1024Ser
missense
Exon 23 of 35ENSP00000528317.1

Frequencies

GnomAD3 genomes
AF:
0.000841
AC:
128
AN:
152142
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000939
AC:
236
AN:
251434
AF XY:
0.000927
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000752
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.00168
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00154
AC:
2256
AN:
1461890
Hom.:
2
Cov.:
34
AF XY:
0.00148
AC XY:
1079
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33480
American (AMR)
AF:
0.000917
AC:
41
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00188
AC:
2094
AN:
1112010
Other (OTH)
AF:
0.00131
AC:
79
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
133
265
398
530
663
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000841
AC:
128
AN:
152260
Hom.:
0
Cov.:
31
AF XY:
0.000819
AC XY:
61
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41550
American (AMR)
AF:
0.000980
AC:
15
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00148
AC:
101
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00145
Hom.:
1
Bravo
AF:
0.00104
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.000964
AC:
117
EpiCase
AF:
0.00180
EpiControl
AF:
0.00243

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
not provided (6)
-
1
-
Cenani-Lenz syndactyly syndrome (1)
-
-
1
Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 (1)
-
-
1
LRP4-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
1.7
DANN
Benign
0.42
DEOGEN2
Benign
0.23
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.57
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
-0.93
N
PhyloP100
0.12
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.77
N
REVEL
Uncertain
0.35
Sift
Benign
1.0
T
Sift4G
Benign
0.79
T
Polyphen
0.0
B
Vest4
0.054
MVP
0.27
MPC
0.43
ClinPred
0.0088
T
GERP RS
-4.2
Varity_R
0.029
gMVP
0.24
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151234321; hg19: chr11-46897434; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.